Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab, Oxaliplatin, 5-FU, and Radiation in Esophageal Cancer
NCT00425425Phase 2Unknown
- Sponsor
- Technical University of Munich
- Start
- Jul 2006
- Primary completion
- May 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Technical University of Munich. Status: unknown.
02
Drugs
cetuximab
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT00425425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425425.